This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Choosing points over cash back can be beneficial in specific situations. Understand when to make that switch for better rewards.
27,195 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
The Trade Desk just fell to a multi-year low, sparking a debate between momentum fans and value hunters. This guide b...
Investors noticed a notable move in jumia technologies stock jumped this week as Jumia reported improving early resul...
As earnings season arrives, sprinklr (cxm) 2026 earnings take center stage for investors watching the CXM software sp...
From 2010 to 2022, real estate investing looked like a smooth ride fueled by easy credit and rising prices. This arti...
AI investing often spotlights flashy chips, but the real winners are the enablers. Rambus sits at the nexus of securi...
A retiree keeping 90% of a $1.7M portfolio in cash faces about $39,000 a year in lost growth, underscoring the long-t...
A big shift in Berkshire’s thinking could put Alphabet in the spotlight for investors. This deep dive explains what t...
How do two AI infrastructure players compare when it comes to revenue scale? This article breaks down the factors, me...
A SpaceX IPO could unlock funding for a bold, space-based data center vision. This deep dive explains what data cente...
Rising oil prices amid escalating tensions weigh on the Dow and broader U.S. markets. This guide breaks down why ener...
Geopolitics rarely stays in headlines for long, but the impact on crypto can be swift and surprising. This guide help...